JPMorgan and Morgan Stanley enhance buybacks and dividends, even though Citigroup and BofA get more compact techniques

JPMorgan and Morgan Stanley enhance buybacks and dividends, even though Citigroup and BofA get more compact techniques


Important Points
  • JPMorgan claimed it was increasing its quarterly dividend 8.7% to $1.25 for every share and that it approved a new $30 billion share repurchase plan.
  • Morgan Stanley mentioned it was boosting its dividend 8.8% to 92.5 cents per share and authorized a $20 billion repurchase system.
  • Citigroup said it was boosting its dividend 5.7% to 56 cents per share and that it would “keep on to assess share repurchases” on a quarterly foundation.
  • Financial institution of America explained it was escalating its dividend 8% to 26 cents for every share its launch made no mention of share repurchases.



Source

Billionaire Ken Griffin’s hedge funds at Citadel are all in the green for 2025
Finance

Billionaire Ken Griffin’s hedge funds at Citadel are all in the green for 2025

Citadel CEO Ken Griffin speaks during the Semafor World Economy Summit 2025 at Conrad Washington on April 23, 2025 in Washington, DC. Kayla Bartkowski | Getty Images Billionaire investor Ken Griffin’s hedge funds at Citadel have all posted positive returns during a volatile 2025, led by the tactical trading fund. Citadel’s multistrategy Wellington fund, its largest, gained […]

Read More
Stocks making the biggest moves midday: Tesla, Tandem Diabetes, GE Vernova, Hasbro and more
Finance

Stocks making the biggest moves midday: Tesla, Tandem Diabetes, GE Vernova, Hasbro and more

Check out the companies making the biggest moves midday: Diabetes tech stocks — The Centers for Medicare & Medicaid Services is proposing a rule change that could change the reimbursement rates for continuous glucose monitors and insulin pumps. The news sent shares of diabetes tech stocks lower. Tandem Diabetes Care and Beta Bionics tumbled 4% […]

Read More
Cliff Asness’ AQR sees multiple hedge funds up double digits in 2025, beating the market
Finance

Cliff Asness’ AQR sees multiple hedge funds up double digits in 2025, beating the market

Key Points AQR Capital Management’s Apex strategy rallied 11.4% in the first six months of the year, according to a person familiar with the fund’s returns. AQR’s long-short Delphi equity fund gained 11.6% net of fees in the first half of 2025, the person said. Its alternative trend-following Helix strategy has returned 7.4% so far […]

Read More